Printer Friendly

BOSTON SCIENTIFIC CORPORATION REPORTS CONTINUED GROWTH IN SALES AND EARNINGS FOR YEAR ENDED DECEMBER 31, 1992

 WATERTOWN, Mass., Feb. 23 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today released results for its fourth quarter and year ended Dec. 31, 1992.
 Net sales for the year increased 37 percent to $315,165,000 from the previous year's $230,035,000. Net earnings for the year increased 36 percent to $56,645,000, or 57 cents per share, from $41,706,000, or 44 cents per share, in the prior year.
 Net sales for the fourth quarter increased 32 percent to $84,353,000 compared to $63,798,000 in the fourth quarter of 1991. Net earnings for the fourth quarter were $15,600,000, or 15 cents per share, compared to $10,555,000, or 11 cents per share, in the prior year.
 Pete Nicholas, co-chairman and chief executive officer, said, "Our business continues to benefit from the substantial investments made over the past ten years. It is our goal to remain focused on the development and commercialization of cost-effective medical devices that promise to enhance the productivity of health care in this country and the world."
 Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices. The company's products are used in a broad range of interventional medical specialties including cardiology, gastroenterology, pulmonary medicine, radiology, urology and vascular surgery.
 BOSTON SCIENTIFIC CORPORATION
 (in thousands, except per share amounts)
 Quarter Ended Year Ended
 December 31, December 31,
 1992 1991 1992 1991
 Net sales $84,353 $63,798 $315,165 $230,035
 Cost of products sold 31,875 24,470 116,532 81,836
 Gross Profit 52,478 39,328 198,633 148,199
 Selling, general and
 administrative
 expenses 22,944 19,454 88,964 67,498
 Research & development
 expenses 4,113 2,257 16,886 10,235
 Total 27,057 21,711 105,850 77,733
 Income from operations 25,421 17,617 92,783 70,466
 Other income (expense)
 Interest income 1,327 188 2,926 421
 Interest expense (663) (583) (2,846) (2,894)
 Other expense (1,175) (81) (1,291) (200)
 Income before income
 taxes 24,910 17,141 91,572 67,793
 Income taxes 9,310 6,586 34,927 26,087
 Net income $15,600 $10,555 $56,645 $41,706
 Net income per share 15 cents 11 cents 57 cents 44 cents
 Weighted average
 number of shares 101,993,671 94,148,575 98,850,814 94,148,575
 -0- 2/23/93
 /CONTACT: Larry Best of Boston Scientific Corporation, 617-972-4450/
 (BSX)


CO: Boston Scientific Corporation ST: Massachusetts IN: MTC SU: ERN

DJ -- NE019 -- 9565 02/23/93 16:25 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 23, 1993
Words:431
Previous Article:NORSTAN TO DISTRIBUTE, INSTALL AND SERVICE CLI'S NEW eclipse VIDEOCONFERENCING PRODUCT
Next Article:BLUE CROSS AND BLUE SHIELD OF MARYLAND ANNOUNCES CONTRACT WITH EDS
Topics:


Related Articles
BOSTON SCIENTIFIC CORPORATION REPORTS INCREASED SALES AND EARNINGS FOR SECOND QUARTER
BOSTON SCIENTIFIC CORPORATION REPORTS INCREASED SALES AND EARNINGS FOR THIRD QUARTER
FISHER SCIENTIFIC FOURTH-QUARTER NET INCOME UP 58 PERCENT
BOSTON SCIENTIFIC CORPORATION REPORTS INCREASED SALES AND EARNINGS FOR SECOND QUARTER
BOSTON SCIENTIFIC CORPORATION ANNOUNCES SALES GROWTH FOURTH QUARTER AND YEAR 1993
BOSTON SCIENTIFIC CORPORATION REPORTS CONTINUED GROWTH IN SALES AND EARNINGS FOR FOURTH QUARTER AND YEAR ENDED DECEMBER 31, 1993
BOSTON SCIENTIFIC CORPORATION REPORTS INCREASED SALES AND EARNINGS FOR FIRST QUARTER
BOSTON SCIENTIFIC CORPORATION REPORTS INCREASED SALES AND EARNINGS FOR THIRD QUARTER
BOSTON SCIENTIFIC CORPORATION ANNOUNCES SALES GROWTH FOURTH QUARTER AND YEAR 1994
BOSTON SCIENTIFIC CORPORATION ANNOUNCES RECORD SALES AND EARNINGS FOR THIRD QUARTER

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters